Scotland · NHS Scotland MSAN
Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour,
MSAN(2025)31 · Level 2 · issued 25 Jun 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| transdermal patches are out of stock until early August 2025. | Out of stock | early August 2025 |
| 2. Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches are out of stock until | Out of stock | — |
| 4. Alternative buprenorphine matrix formulation 4-day (96-hourly) patches remain available | Available | — |
| (Bupeaze® [35micrograms/hour and 70micrograms/hour strengths remain available], | Available | — |
| formulation 4-day (96-hourly) transdermal patch that is available including: Bupeaze® | Available | — |
| (35micrograms/hour and 70micrograms/hour remain available), Carlosafine®, and Transtec® | Available | — |
| analgesics. They are available as matrix formulations (drug embedded in an adhesive matrix | Available | — |
| 8. Buprenorphine patches are available in lots of different strengths and durations of action (72 | Available | — |
| buprenorphine patch which is available in the same strengths as Relevtec® and Bupeaze® (e.g. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.